NCT04710342 (CapBuster) is a NA clinical trial of CapBuster in Chronic Total Occlusion, sponsored by Praxis Medical Devices Ltd.

Who is sponsoring NCT04710342?

NCT04710342 is sponsored by Praxis Medical Devices Ltd.

What drugs are being tested in NCT04710342?

Interventions in NCT04710342: CapBuster.

What condition does NCT04710342 study?

NCT04710342 studies Chronic Total Occlusion.

Is NCT04710342 still recruiting?

NCT04710342 is currently status unknown. Last updated 21 February 2023.

Last reviewed 2023-02-21 · How we verify

NCT04710342: CapBuster

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Study Evaluating Use of the CapBuster Medical Device System for the Crossing of Chronic Total Occlusions

Status unknown NA Last updated 21 February 2023

What this trial tests

NA trial testing CapBuster in Chronic Total Occlusion in 26 participants. Status unknown.

Timeline

21 June 2021

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Praxis Medical Devices Ltd
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	26
Start date	21 June 2021
Primary completion	31 December 2023
Estimated completion	31 December 2023
Sites	1 location across Netherlands

Drugs / interventions tested

CapBuster

Conditions studied

Chronic Total Occlusion — all drugs for Chronic Total Occlusion →

Sponsor

Praxis Medical Devices Ltd

Who can join

18 and older, any sex, with Chronic Total Occlusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study represents a prospective, non-randomized, dual-center clinical study to evaluate the safety and effectiveness of the CapBuster System in crossing a de novo or restenotic infrapopliteal chronic total occlusion. Measures of safety and efficacy will be assessed through 30 days post-intervention.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Chronic Total Occlusion

Currently open trials in the same condition.

NCT06137521 — Risk Factors and Outcomes in Coronary Chronic Total Occlusion · recruiting

Other Praxis Medical Devices Ltd trials

Trials by the same sponsor.

NCT05733481 — Evaluating the Use of the CapBuster System for the Crossing of CTO's in Coronary Arteries · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04710342 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Praxis Medical Devices Ltd
Last refreshed: 21 February 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04710342.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing